Stocks to buy: IT & pharma are good but better to go with co

Stocks to buy: IT & pharma are good but better to go with consumer discretionaries: Pankaj Murarka


How have you looked at the overall earnings trajectory so far?
The numbers so far have been pretty decent. There have been some minor dips here and there, but broadly they have been pretty healthy and very much in line with expectations. There have been some positive surprises as well.
ICICI Bank surprised big times over the weekend in terms of the numbers they reported. The incremental NPAs are much lower and the provisioning was also much lower and they have given a very healthy outlook going forward to the next year. Likewise, we have seen a pretty healthy set of numbers from IT companies and more importantly the guidance for next year.

Related Keywords

China , Japan , India , United Kingdom , Israel , Pankaj Murarka , Indian Hotels , Renaissance Investment , Bajaj Finance , Stocks To Buy , Cred , Renaissance Investment Managers , Earnings Growth , Positive Surprises , Consumer Discretionaries , Et Now , Stock Market , சீனா , ஜப்பான் , இந்தியா , ஒன்றுபட்டது கிஂக்டம் , இஸ்ரேல் , பங்கஜ் முரர்கா , இந்தியன் ஹோட்டல் , மறுமலர்ச்சி முதலீடு , பஜாஜ் நிதி , ஸ்டாக்ஸ் க்கு வாங்க , கடன் , மறுமலர்ச்சி முதலீடு மேலாளர்கள் , மற்றும் பலர் இப்போது , ஸ்டாக் சந்தை ,

© 2025 Vimarsana